These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7381692)

  • 21. CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations.
    Lorenzin A; Garzotto F; Alghisi A; Neri M; Galeano D; Aresu S; Pani A; Vidal E; Ricci Z; Murer L; Goldstein SL; Ronco C
    Pediatr Nephrol; 2016 Oct; 31(10):1659-65. PubMed ID: 27139897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative pharmacokinetics of theophylline in peritoneal dialysis and hemodialysis.
    Lee CS; Peterson JC; Marbury TC
    J Clin Pharmacol; 1983 Jul; 23(7):274-80. PubMed ID: 6886029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition kinetics of ethambutol in man.
    Lee CS; Brater DC; Gambertoglio JG; Benet LZ
    J Pharmacokinet Biopharm; 1980 Aug; 8(4):335-46. PubMed ID: 7431225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodialysis of mefenamic acid in uremic patients.
    Wang LH; Lee CS; Marbury TC
    Am J Hosp Pharm; 1980 Jul; 37(7):956-8. PubMed ID: 7395889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo effects of dialysate flow rate on Kt/V in maintenance hemodialysis patients.
    Hauk M; Kuhlmann MK; Riegel W; Köhler H
    Am J Kidney Dis; 2000 Jan; 35(1):105-11. PubMed ID: 10620551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodialysis clearance of total and unbound lidocaine.
    Jacobi J; McGory RW; McCoy H; Matzke GR
    Clin Pharm; 1983; 2(1):54-7. PubMed ID: 6883930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo.
    Sombolos K; Tsitamidou Z; Kyriazis G; Karagianni A; Kantaropoulou M; Progia E
    Am J Nephrol; 1997; 17(5):406-12. PubMed ID: 9382156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.
    Gerig JS; Bolton ND; Swabb EA; Scheld WM; Bolton WK
    Kidney Int; 1984 Sep; 26(3):308-18. PubMed ID: 6542606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The Effect of Dialysate Flow Rate on Dialysis Adequacy and Fatigue in Hemodialysis Patients].
    Cha SM; Min HS
    J Korean Acad Nurs; 2016 Oct; 46(5):642-652. PubMed ID: 27857008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cefamandole kinetics in uremic patients undergoing hemodialysis.
    Gambertoglio JG; Aziz NS; Lin ET; Grausz H; Naughton JL; Benet LZ
    Clin Pharmacol Ther; 1979 Nov; 26(5):592-9. PubMed ID: 498702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-Dose Pharmacokinetics and Safety of Meropenem-Vaborbactam in Subjects with Chronic Renal Impairment.
    Rubino CM; Bhavnani SM; Loutit JS; Lohse B; Dudley MN; Griffith DC
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. pO2 and pCO2 increment in post-dialyzer blood: the role of dialysate.
    Sombolos KI; Bamichas GI; Christidou FN; Gionanlis LD; Karagianni AC; Anagnostopoulos TC; Natse TA
    Artif Organs; 2005 Nov; 29(11):892-8. PubMed ID: 16266303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and safety of iomeprol in healthy volunteers and in patients with renal impairment or end-stage renal disease requiring hemodialysis.
    Lorusso V; Taroni P; Alvino S; Spinazzi A
    Invest Radiol; 2001 Jun; 36(6):309-16. PubMed ID: 11410750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of hemodialysis on isoniazid, rifampin, pyrazinamide, and ethambutol.
    Malone RS; Fish DN; Spiegel DM; Childs JM; Peloquin CA
    Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1580-4. PubMed ID: 10228130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of hemodialysis on the pharmacokinetics of ibuprofen and its major metabolites.
    Antal EJ; Wright CE; Brown BL; Albert KS; Aman LC; Levin NW
    J Clin Pharmacol; 1986 Mar; 26(3):184-90. PubMed ID: 3958223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers.
    McCarthy JT; Jenson BM; Squillace DP; Williams AW
    Am J Kidney Dis; 1997 Apr; 29(4):576-83. PubMed ID: 9100048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of dialyzer jacket structure and hollow-fiber dialysis membranes to achieve high dialysis performance.
    Hirano A; Yamamoto K; Matsuda M; Ogawa T; Yakushiji T; Miyasaka T; Sakai K
    Ther Apher Dial; 2011 Feb; 15(1):66-74. PubMed ID: 21272255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clearance of 131I by hemodialysis.
    Culpepper RM; Hirsch JI; Fratkin MJ
    Clin Nephrol; 1992 Aug; 38(2):110-4. PubMed ID: 1516279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability of ⁵¹Cr-EDTA plasma and urinary clearance as a measure of residual renal function in dialysis patients.
    Kjaergaard KD; Jensen JD; Jespersen B; Rehling M
    Scand J Clin Lab Invest; 2011 Dec; 71(8):663-9. PubMed ID: 21992070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imprecision of the hemodialysis dose when measured directly from urea removal. Hemodialysis Study Group.
    Depner TA; Greene T; Gotch FA; Daugirdas JT; Keshaviah PR; Star RA
    Kidney Int; 1999 Feb; 55(2):635-47. PubMed ID: 9987088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.